Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 137

1.

Willingness to pay for rapid diagnostic tests for the diagnosis and treatment of malaria in southeast Nigeria: ex post and ex ante.

Uzochukwu BS, Onwujekwe OE, Uguru NP, Ughasoro MD, Ezeoke OP.

Int J Equity Health. 2010 Jan 15;9:1. doi: 10.1186/1475-9276-9-1.

2.

Willingness to pay for community-based health insurance in Nigeria: do economic status and place of residence matter?

Onwujekwe O, Okereke E, Onoka C, Uzochukwu B, Kirigia J, Petu A.

Health Policy Plan. 2010 Mar;25(2):155-61. doi: 10.1093/heapol/czp046. Epub 2009 Oct 26.

PMID:
20156920
3.

Ex post and ex ante willingness to pay (WTP) for the ICT Malaria Pf/Pv test kit in Myanmar.

Cho-Min-Naing, Lertmaharit S, Kamol-Ratanakul P, Saul AJ.

Southeast Asian J Trop Med Public Health. 2000 Mar;31(1):104-11.

PMID:
11023075
4.
5.
6.

Willingness-to-pay for a rapid malaria diagnostic test and artemisinin-based combination therapy from private drug shops in Mukono District, Uganda.

Hansen KS, Pedrazzoli D, Mbonye A, Clarke S, Cundill B, Magnussen P, Yeung S.

Health Policy Plan. 2013 Mar;28(2):185-96. doi: 10.1093/heapol/czs048. Epub 2012 May 15.

7.
8.

Cost benefit analysis of malaria rapid diagnostic test: the perspective of Nigerian community pharmacists.

Ezennia IJ, Nduka SO, Ekwunife OI.

Malar J. 2017 Jan 3;16(1):7. doi: 10.1186/s12936-016-1648-0.

9.

A cost-benefit analysis using contingent valuation techniques: a feasibility study in spinal surgery.

Haefeli M, Elfering A, McIntosh E, Gray A, Sukthankar A, Boos N.

Value Health. 2008 Jul-Aug;11(4):575-88. doi: 10.1111/j.1524-4733.2007.00282.x. Epub 2007 Dec 19.

11.

Investigating starting-point bias: a survey of willingness to pay for insecticide-treated nets.

Onwujekwe O, Nwagbo D.

Soc Sci Med. 2002 Dec;55(12):2121-30.

PMID:
12409125
12.

Willingness to pay for a reduction in mortality risk after a myocardial infarction: an application of the contingent valuation method to the case of eplerenone.

Pinto-Prades JL, Farreras V, de Bobadilla JF.

Eur J Health Econ. 2008 Feb;9(1):69-78. Epub 2007 Apr 20.

PMID:
17447095
13.

Are malaria treatment expenditures catastrophic to different socio-economic and geographic groups and how do they cope with payment? A study in southeast Nigeria.

Onwujekwe O, Hanson K, Uzochukwu B, Ichoku H, Ike E, Onwughalu B.

Trop Med Int Health. 2010 Jan;15(1):18-25. doi: 10.1111/j.1365-3156.2009.02418.x. Epub 2009 Nov 3.

14.

Willingness to pay for community-based ivermectin distribution: a study of three onchocerciasis-endemic communities in Nigeria.

Onwujekwe OE, Shu EN, Nwagbo D, Akpala CO, Okonkwo PO.

Trop Med Int Health. 1998 Oct;3(10):802-8.

15.

Altruistic willingness to pay in community-based sales of insecticide-treated nets exists in Nigeria.

Onwujekwe O, Chima R, Shu E, Nwagbo D, Akpala C, Okonkwo P.

Soc Sci Med. 2002 Feb;54(4):519-27.

PMID:
11848272
16.

Socio-economic differences in preferences and willingness to pay for different providers of malaria treatment in southeast Nigeria.

Onwujekwe O, Ojukwu J, Ezumah N, Uzochukwu B, Dike N, Soludo E.

Am J Trop Med Hyg. 2006 Sep;75(3):421-9.

PMID:
16968915
17.

Quantifying the economic burden of malaria in Nigeria using the willingness to pay approach.

Jimoh A, Sofola O, Petu A, Okorosobo T.

Cost Eff Resour Alloc. 2007 May 22;5:6. doi: 10.1186/1478-7547-5-6.

18.
19.

Patients' willingness to pay for the treatment of tuberculosis in Nigeria: exploring own use and altruism.

Ochonma OG, Onwujekwe OE.

Int J Equity Health. 2017 May 10;16(1):74. doi: 10.1186/s12939-017-0574-2.

20.

Willingness and ability to pay for artemisinin-based combination therapy in rural Tanzania.

Saulo EC, Forsberg BC, Premji Z, Montgomery SM, Björkman A.

Malar J. 2008 Oct 31;7:227. doi: 10.1186/1475-2875-7-227.

Supplemental Content

Support Center